EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ornithine decarboxylase and its role in cancer

Jessica Georgina Filisola-Villaseñor, Beatriz Irene Arroyo-Sánchez, Luis Janiel Navarro-González, Edgar Morales-Ríos, Viridiana Olin-Sandoval

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Jessica Georgina Filisola-Villaseñor und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico. Hauptthemen laut MEDLINE: Ornithine Decarboxylase, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 221 Literaturangaben. Gefördert von: Consejo Nacional de Humanidades, Ciencias y Tecnologías.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is among the leading causes of death worldwide. The effectiveness of conventional chemotherapy has some drawbacks, therefore, there is an urgency to develop novel strategies to fight this disease. Ornithine decarboxylase (ODC) is the most finely tuned enzyme of the polyamine (PA) biosynthesis pathway as it is regulated at different levels: transcriptional, translational, post-translational, and by feedback inhibition. In cancer, this enzyme is overexpressed due to its regulation by the protooncogene c-Myc, thus it has been proposed as a drug target against this disease. This review describes information regarding the biochemistry and regulation of the ODC at different levels and its role in cancer. Moreover, we discuss the molecules aiming on the inhibition of the ODC activity that have been tested as therapeutic options. ODC remains as a therapeutic opportunity that needs to be more explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ornithine DecarboxylaseNeoplasmsHumansAnimalsOrnithine Decarboxylase InhibitorsPolyaminesProto-Oncogene Proteins c-myc

Stichwörter der Autor:innen

CancerChemotherapeuticOrnithine decarboxylasePolyaminesc-Myc

Substanzen

Ornithine DecarboxylaseOrnithine Decarboxylase InhibitorsPolyaminesProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Department of Biochemistry, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
  • Department of Biotechnology and Bioengineering, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico.
  • Department of Biochemistry, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico. Electronic address: edgar.morales@cinvestav.mx.
  • Department of Biotechnology and Bioengineering, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Mexico City, Mexico. Electronic address: viridiana.olin@cinvestav.mx.

Förderung

  • Consejo Nacional de Humanidades, Ciencias y Tecnologías

Zitieren

APA

Filisola-Villaseñor, J. G., Arroyo-Sánchez, B. I., Navarro-González, L. J., Morales-Ríos, E., & Olin-Sandoval, V. (2025). Ornithine decarboxylase and its role in cancer. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110321

Vancouver

Filisola-Villaseñor JG, Arroyo-Sánchez BI, Navarro-González LJ, Morales-Ríos E, Olin-Sandoval V. Ornithine decarboxylase and its role in cancer. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110321

BibTeX
@article{FilisolaVillaseor2025,
  author = {Filisola-Villaseñor, Jessica Georgina and Arroyo-Sánchez, Beatriz Irene and Navarro-González, Luis Janiel and Morales-Ríos, Edgar and Olin-Sandoval, Viridiana},
  title = {Ornithine decarboxylase and its role in cancer},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110321}
}
Kostenlos starten →